Microarray-based Analysis of Genes, Transcription Factors, and Epigenetic Modifications in Lung Cancer Exposed to

Arnatchai Maiuthed1, Ornjira Prakhongcheep2,3, Pithi Chanvorachote4,3

  • 1Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.

Abstract

Insights

Nitric oxide (NO) regulates 151 genes in lung cancer cells, affecting transcription factors and epigenetic modifications. This study reveals NO

Area of Science:

  • Molecular biology
  • Cancer research
  • Bioinformatics

Background:

  • Nitric oxide (NO) is a key biological mediator influencing cell signaling and cancer phenotypes.
  • Understanding NO's diverse effects on cancer cells is crucial for therapeutic strategies.

Purpose of the Study:

  • To elucidate the regulatory mechanisms and molecular pathways of nitric oxide (NO) in non-small cell lung cancer.
  • To identify genes and transcription factors modulated by NO in lung cancer.

Main Methods:

  • Bioinformatics analysis of gene expression data.
  • Pharmacological experiments in a non-small cell lung cancer model.
  • Microarray analysis to identify NO-regulated genes.

Main Results:

  • Identified 151 differentially expressed genes (80 up, 71 down) regulated by NO.
  • Observed significant changes in transcription factors and epigenetic modifications (histone modification, miRNA) upon NO exposure.
  • NO treatment potentiated cancer stem cell-related genes and transcription factors (Oct4, Klf4, Myc).

Conclusions:

  • Nitric oxide significantly impacts molecular events in lung cancer cells.
  • The study provides a comprehensive overview of NO's molecular effects in lung cancer.
  • Findings contribute to understanding NO's role and potential therapeutic applications in lung cancer.

Related Concept Videos